98%
921
2 minutes
20
Since permanent inferior vena cava (IVC) filters increase deep vein thrombosis (DVT), filter retrieval should be performed as possible. Despite the guideline recommendation, IVC filters are not always retrieved in clinical practice. To date, many patients with not-retrieval IVC filters have been prescribed anticoagulant therapy, but the long-term prognosis, including venous thromboembolism (VTE) and bleeding events, remains unknown. In this study, 195 patients who underwent IVC filter implantation between 2006 and 2017 at 3 institutions in Niigata City have been investigated about their deaths, VTE recurrence, and bleeding events. After peaking 2009, the number of IVC filter implantation gradually decreased. During observational period, there were 158 patients with not-retrieval IVC filters (the overall retrieval rate of 19.0%). The not-retrieval group included significantly older and more patients with cancer compared to the retrieval group. Anticoagulation therapy was continued in 88% of the not-retrieval group. During a mean follow-up of 5.0 years, 6 symptomatic DVT events associated with inadequate control of anticoagulation and 13 bleeding events were observed. A total of 52 patients died and only the presence of cancer was prognostic risk factor. Although long-term anticoagulation therapy may be associated with bleeding events, there were few recurrent VTE under optimal anticoagulation. It is anticipated that even if the IVC filter cannot be retrieved, appropriate anticoagulation is useful for prevention of DVT recurrence despite the risk of bleeding.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1536/ihj.21-814 | DOI Listing |
JACC Adv
August 2025
CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain; Chair for the Study of Thromboembolic Disease, Faculty of Health Sciences, UCAM-Universidad Católica San Antonio de Murcia, Guadalupe, Spain. Electronic address:
Background: Patients with cancer-associated venous thromboembolism (VTE) are at increased risk of both recurrent VTE and bleeding. These risks may vary by cancer site, but the magnitude of this variation remains unclear.
Objectives: The aim of the study was to compare 90-day risks of recurrent VTE or VTE-related death (composite outcome) and major bleeding across different cancer sites.
World J Clin Cases
September 2025
Department of Critical Care Medicine, The Second Affiliated Hospital of Zunyi Medical University, Zunyi 563000, Guizhou Province, China.
Background: Acute pulmonary thromboembolism is a complication of venous thrombosis. Extracorporeal membrane oxygenation (ECMO), an effective rescue measure for rapid hemodynamic recovery, can be used in patients for whom thrombolysis therapy has failed.
Case Summary: This case report describes an extreme rescue process for a patient with a preset inferior vena cava (IVC) filter in a relatively economically underdeveloped area with an insufficient supply of consumables.
Thromb Res
August 2025
Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States of America; Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States of America; Yale New Haven Hospital/Yale Center for Outcomes Res
Thromb Haemost
August 2025
Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
Lipoprotein(a) [Lp(a)] is a circulating plasma lipoprotein with structural similarities to low-density lipoprotein (LDL), distinguished by the addition of apolipoprotein(a) to the LDL structure. Lp(a) levels are approximately 80% genetically determined, and distinct components of this complex particle are thought to confer atherogenic, inflammatory, and antifibrinolytic properties contributing to cardiovascular risk. A growing body of evidence has shown a causal association between elevated Lp(a) levels and both atherosclerotic cardiovascular disease (ASCVD) and valvular aortic stenosis.
View Article and Find Full Text PDFBMJ Case Rep
August 2025
Internal Medicine, The University of Kansas Medical Center, Kansas City, Kansas, USA
We discuss the complications associated with inferior vena cava (IVC) filters, focusing on a female patient in her mid-30s who presented to the emergency department with a history of hypercoagulable state and recurrent deep vein thrombosis. She had an IVC filter placed, followed by an IVC stent years later. The patient presented with severe lower back pain radiating to her right leg and back spasms.
View Article and Find Full Text PDF